These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 25118484)
1. Comparison of pelvic masses score (PMS) and Risk of Malignancy Index (RMI 3) in the evaluation of pelvic masses. Rossi A; Forzano L; Romanello I; Ambrosini G; Iuri V; Marchesoni D Eur J Gynaecol Oncol; 2014; 35(4):421-4. PubMed ID: 25118484 [TBL] [Abstract][Full Text] [Related]
2. A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS). Rossi A; Braghin C; Soldano F; Isola M; Capodicasa V; Londero AP; Forzano L; Marchesoni D Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):84-8. PubMed ID: 21440361 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors. Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390 [TBL] [Abstract][Full Text] [Related]
4. The risk of malignancy with an apparently simple adnexal cyst on ultrasound. Obwegeser R; Deutinger J; Bernascheck G Arch Gynecol Obstet; 1993; 253(3):117-20. PubMed ID: 8250597 [TBL] [Abstract][Full Text] [Related]
5. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor. Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561 [TBL] [Abstract][Full Text] [Related]
6. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy. Moolthiya W; Yuenyao P Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854 [TBL] [Abstract][Full Text] [Related]
7. Simple descriptors and simple rules of the International Ovarian Tumor Analysis (IOTA) Group: a prospective study of combined use for the description of adnexal masses. Peces Rama A; Llanos Llanos MC; Sánchez Ferrer ML; Alcázar Zambrano JL; Martínez Mendoza A; Nieto Díaz A Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():7-11. PubMed ID: 26461961 [TBL] [Abstract][Full Text] [Related]
8. [Transvaginal ultrasonography and nuclear magnetic resonance. Comparison of techniques in the evaluation of ovarian lesions]. Mascaretti G; Carta G; Renzi E; Peluzzi C; Bonitatibus A; Di Francesco CL; Patacchiola F; Moscarini M Minerva Ginecol; 1994 Nov; 46(11):591-5. PubMed ID: 7854561 [TBL] [Abstract][Full Text] [Related]
9. Risk of malignancy index in the preoperative evaluation of pelvic masses. Obeidat BR; Amarin ZO; Latimer JA; Crawford RA Int J Gynaecol Obstet; 2004 Jun; 85(3):255-8. PubMed ID: 15145261 [TBL] [Abstract][Full Text] [Related]
10. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881 [TBL] [Abstract][Full Text] [Related]
11. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass. Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C; Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703 [TBL] [Abstract][Full Text] [Related]
12. Risk of malignancy index in preoperative evaluation of pelvic masses. Ashrafgangooei T; Rezaeezadeh M Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553 [TBL] [Abstract][Full Text] [Related]
13. Serum C-reactive protein in the differential diagnosis of ovarian masses. Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of ovarian tumors by sonography]. Wu ZY; Zhang GY; Du ZB Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):100-2, 125. PubMed ID: 8033625 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Morgante G; la Marca A; Ditto A; De Leo V Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607 [TBL] [Abstract][Full Text] [Related]
17. Role of a risk of malignancy index in clinical approaches to adnexal masses. Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065 [TBL] [Abstract][Full Text] [Related]
18. Comparison of nine morphological scoring systems to detect ovarian malignancy. Aktürk E; Dede M; Yenen MC; Koçyiğit YK; Ergün A Eur J Gynaecol Oncol; 2015; 36(3):304-8. PubMed ID: 26189258 [TBL] [Abstract][Full Text] [Related]
19. [Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses]. Lou HY; Meng H; Zhu QL; Zhang Q; Jiang YX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):297-302. PubMed ID: 20602883 [TBL] [Abstract][Full Text] [Related]
20. [Value of multidetector computed tomography in differentiating ovarian tumors from non-ovarian masses]. Rao SX; Zeng MS; Cheng WZ; Yang S; Miao XY; Zhang LJ; Chen G Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):856-9. PubMed ID: 18396647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]